Skip to Main Content

KRISTIE A. BLUM MD, Assistant Professor of Internal Medicine, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

BRETT THOMAS BRINKER MD, Hematology/Oncology Fellow, Division of Hematology/ Oncology, Northwestern University Feinberg School of Medicine, Chicago, Ilinois, USA

JOHN C. BYRD MD, Associate Professor of Medicine and Medicinal Chemistry, D. Warren Brown Professor in Leukemia Research, Director of Hematologic Malignancies, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

BRUCE D. CHESON MD, Professor of Medicine, Division of Hematology/Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA

BERTRAND COIFFIER MD, Professor of Haematology, Depertment of Haematology, Hospices Civils de Lyon and University, Lyon, France

MORTON COLEMAN, MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

MYRON STEFAN CZUCZMAN MD, Head, Lymphoma/Myeloma Service, Associate Professor of Medicine, Division of Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA

JULIE P. DEANS PhD, Associate Professor, AHFMR Senior Scholar Chair, Immunology Research Group, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada

JULIAN DECTER MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

NANCY DRISCOLL RPA-C, Division of Haematology and Oncology, Long Island Jewish Medical Center, New York, New York, USA

VIVIANE DUBRUILLE PhD, Doctor of Haematology, Hotel Dieu, University Hospital, Nantes, France

MARTIN J. S. DYER MA, DPhil, FRCP, FRCPath, Professor of Haemato-Oncology, MRC Toxicology Unit / Leicester University, Leicester, UK

CHRISTOS EMMANOUILIDES MD, Associate Professor, Division of Hematology and Oncology, UCLA, currently: Interbalkan European Medical Center-Oncology, Pylaia, Thessaloniki, Greece

RICHARD R. FURMAN MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

DAVID M. GOLDENBERG MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

LEO I. GORDON MD, Abby & John Friend Professor of Cancer Research, Chief, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago Ilinois, USA

TERRY J. HAMBLIN DM, FRCP, FRCPath, FMedSci, Professor of Immunohaematology, University of Southampton, Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK

JEAN-LUC HAROUSSEAU MD, Professor of Haematology, Hotel Dieu, University Hospital, Nantes, France

FRANCISCO J. HERNANDEZ-ILIZALITURRI MD, Assistant Professor of Medicine, Department of Medical Oncology. Member of the Tumor Immunology Program, Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA

PETER HILLMEN MRCP, MRCPath, PhD, Department of Haematology, Pinderfields Hospital, Wakefield, UK

IVAN D. HORAK MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

ANDREW JACK BSc, MB, ChB, PhD, Consultant Haematopathologist, Haematological Malignancy Diagnostic Service (HMDS), Leeds General Infirmary, Leeds, UK

ANDRZEJ J. JAKUBOWIAK MD, PhD, Assistant Professor of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA

DALE M. JANSON RPA-C, MBA, Division of Haematology and Oncology, Long Island Jewish Medical Center, New York, New York, USA

MARK S. KAMINSKI MD, Professor of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA

MICHAEL KEATING MD, Professor of Medicine, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

PETER MCLAUGHLIN MD, Professor of Medicine, Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

JOHN P. LEONARD MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

THOMAS S. LIN MD, PhD, Assistant Professor of Internal Medicine, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

BLANCHE H. MAVROMATIS MD, Assistant Professor of Medicine, Lombardi Comprehensive Cancer Center, Washington, DC, USA

HĂ…KAN MELLSTEDT MD, PhD, Professor of Oncologic Biotherapy, Department of Oncology (Radiumhemmet), Karolinska University Hospital Solna, Stockholm, Sweden

SUSAN M. O'BRIEN MD, Professor, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

DILIP V. PATEL MD, Division of Haematology and Oncology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, Bronx, New York, New York, USA

KARL S. PEGGS BM, BCh, MA, MRCP, MRCPath, Senior Lecturer in Bone Marrow Transplantation, Department of Haematology, University College Hospital, Royal Free and University College London Medical School, London, UK

KANTI R. RAI MD, Chief, Division of Haematology and Oncology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, Bronx, New York, New York, USA

FARHAD RAVANDI MD, Assistant Professor of Medicine, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

NANCY LOU TUINSTRA RN, Mayo Clinic College of Medicine, Nuclear Medicine, Rochester, Minnesota, USA

WILLIAM A. WEGENER MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

THOMAS E. WITZIG MD, Professor of Medicine, Division of Internal Medicine and Hematology, Mayo Clinic, Rochester, Minnesota, USA

KARENW. L. YEE MD, Fellow, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.